Atomo Diagnostics is a high-growth medical device company that makes testing for infectious and chronic diseases safe, accurate and accessible.
Atomo is working directly with healthcare workers, consumers and industry partners to create innovative solutions that address unmet user needs in rapid tests.
Atomo’s solutions improve the ease of use and reliability of rapid tests across a wide range of applications and settings.
Since being set up in 2010, Atomo has been focused on improving the safety and accuracy of rapid diagnostic tests (RDTs) in the field. The result of this focus is AtomoRapid™, an award winning rapid test platform that integrates the multiple components necessary for performing a rapid test, into a simple easy to use test device.
AtomoRapid™ supports a range of high volume blood based applications including the detection of infectious diseases, measuring markers and hormone levels as well as screening for chronic conditions.
AtomoRapid™ obsoletes the need to use complicated ‘bits in box’ test kits that despite causing significant errors in the field, are currently used to support hundreds of millions of rapid tests globally each year. With its improved convenience, safety and ease of use, AtomoRapid™ has already started to disrupt these chemistry set test kits in the market. The technology is well proven with tests already launched for HIV and malaria, with other applications nearing commercial release. Importantly, healthcare professionals overwhelming prefer AtomoRapid™ over existing test kits due to its safety and convenience.
The significant improvements in usability, when compared with standard test kits, make AtomoRapid™ ideal for self-test consumer applications and Atomo is well advanced with the commercialisation of a number self-test product variants coming to market in 2016.
Atomo also offers other diagnostic companies the opportunity to upgrade their own lateral flow test assays in non-competitive areas. These company’s can source custom AtomoRapid™ cassettes in order to offer their customers improved user satisfaction and performance in an increasing commoditised market place.
Atomo Diagnostics is committed to providing the highest quality products that meet international standards for medical devices and equipment. The company and its operations are fully compliant to international medical device standards and certified to ISO 13485 and ISO 9001 for the design, development and manufacture of In-Vitro Diagnostics.
Atomo’s product innovation and potential to disrupt the healthcare industry has been recognised with multiple international awards:
Atomo is a proud member of leading healthcare industry associations: